Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Toulouse Cedex 1, France Clinical Trials

A listing of Toulouse Cedex 1, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

The TARGET BP OFF-MED Trial

To obtain an assessment of the efficacy and safety of renal denervation by alcohol-mediated neurolysis using the Peregrine Kit in hypertensive subjects in the absence of antihypertensive medications.

Phase

0.0 miles

Learn More »

Evaluation of the Effect of Custom Compression Garments on Standing Static Balance in Ehlers Danlos Syndrome

To evaluate the effect of CG on standing static balance in patients with SED, this study is a pilot study, carried out according to a cross-over scheme of type AB/BA. Each patient will benefit from 2 posturological evaluations, namely without CG (treatment A) and with CG (treatment B). Patients will ...

Phase N/A

0.0 miles

Learn More »

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

This study will evaluate the long-term safety and efficacy of Bimatoprost SR in patients with open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR studies (192024-091, -092, -093, or -095) and received Bimatoprost SR.

Phase

0.0 miles

Learn More »

Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

This is a double-blind, multi-centre, randomised, vehicle-controlled, within-subject trial. The trial is designed to establish the efficacy and safety of delgocitinib cream in the treatment of adult subjects with discoid lupus erythematosus (DLE).

Phase

0.0 miles

Learn More »

Safety and Effectiveness of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML) a Cancer of the Blood

The medical condition being investigated is relapsed or refractory AML in patients aged 1 month to 21 years with Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) mutations (FLT3-ITD AML), following failure of front-line intensive chemotherapy. The trial will be conducted in multiple phases, using an adaptive ...

Phase

2.7 miles

Learn More »